产后肌水平变化对新生儿血甘胺度的影响
Haruka Tsushita1, Ryota Tanaka2, Masanori Inoue3
1Department of Clinical Pharmacy, Oita University Hospital, 1-1 Idaigaoka, Hasama, Yufu, Oita, 879-5593, Japan.
Pharmaceutical research
|March 17, 2026
概括
在新生儿中用Gentamicin的剂量需要仔细考虑功能. 经月经后的年龄 (PMA) 是初始 gentamicin (GM) 剂量的关键,而肌素 (Cr) 水平指导后来的调整.
科学领域:
- 新生儿药理学 新生儿药理学
- 儿科脏病学 儿科脏病学
- 药物剂量优化 药物剂量优化
背景情况:
- جنت素 (GM) 是新生儿感染的关键抗生素,通过脏排出.
- 目前新生儿转基因剂量取决于体重和月经后年龄 (PMA).
- 血清肌氨酸 (Cr) 是功能标志物,但出生时的Cr可能会受到母亲水平的影响.
研究的目的:
- 确定新生儿中低谷 gentamicin (GM) 度的关键决定因素.
- 评估功能参数在预测转基因水平方面的作用.
- 在新生儿群体中优化转基因剂量策略.
主要方法:
- 78名接受IVGM的新生儿进行了回顾性,单中心的观察性研究.
- 剂量按出生体重分层,具体方案为<1200g,1200-1999g和≥2000g.
- 对Cr在出生时 (Cr出生),Cr在转基因开始后 (CrGM),PMA和尿液输出的剂量正常化低谷GM度 (C/D) 的分析.
主要成果:
- 在较低出生体重组中,CrGM明显高于Cr出生.
- 剂量正常化的低谷GM度 (C/D) 与PMA,CrGM和尿液输出相关,但不是Cr出生.
- 在使用出生参数时,月经后年龄 (PMA) 预测了C/D;然而,在包括开始后参数时,C出生成为唯一的预测因素.
结论:
- 经月经后的年龄 (PMA) 是0.0日初始珍塔米辛 (GM) 剂量的一个合适因素.
- 基于肌素 (Cr) 的功能参数在指导维护转基因剂量方面更有效.
- 精细的剂量策略可以改善新生儿的治疗药物监测.
相关概念视频
01:15Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
308
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
308
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
360
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
360
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
308
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
308
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
313
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
313
01:25Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance
331
In healthy individuals, serum creatinine levels remain stable due to a balance between its constant production—primarily from muscle metabolism—and renal excretion. Creatinine is freely filtered by the glomeruli, making it a valuable marker for estimating renal function. When the glomerular filtration rate (GFR) decreases, the kidneys can only eliminate less creatinine, causing serum levels to rise.Serum creatinine concentration is widely used to estimate creatinine clearance...
331
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
423
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
423